Literature DB >> 24335998

Splenectomy prior to allogeneic hematopoietic SCT increases the risk of post-transplant lymphoproliferative disease.

M Uhlin1, M M Norström2, J Mattsson2, M Remberger2.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24335998     DOI： 10.1038/bmt.2013.201

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  11 in total

1.  A European multicenter study of chronic graft-versus-host disease. The role of cytomegalovirus serology in recipients and donors--acute graft-versus-host disease, and splenectomy.

Authors:  L Boström; O Ringdén; N Jacobsen; F Zwaan; B Nilsson
Journal:  Transplantation       Date:  1990-06       Impact factor: 4.939

Review 2.  Non-MALT marginal zone lymphoma.

Authors:  Catherine Thieblemont; Frederic Davi; Maria-Elena Noguera; Josette Brière
Journal:  Curr Opin Hematol       Date:  2011-07       Impact factor: 3.284

3.  Preventive effect of IgG from EBV-seropositive donors on the development of human lympho-proliferative disease in SCID mice.

Authors:  M R Abedi; A Linde; B Christensson; M Mackett; L Hammarström; C I Smith
Journal:  Int J Cancer       Date:  1997-05-16       Impact factor: 7.396

4.  Risk factors for Epstein-Barr virus-related post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation.

Authors:  Michael Uhlin; Helena Wikell; Mikael Sundin; Ola Blennow; Markus Maeurer; Olle Ringden; Jacek Winiarski; Per Ljungman; Mats Remberger; Jonas Mattsson
Journal:  Haematologica       Date:  2013-09-20       Impact factor: 9.941

5.  Allogeneic haematopoietic stem cell transplantation for myelofibrosis: a report of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Authors:  Marie Robin; Reza Tabrizi; Mohamad Mohty; Sabine Furst; Mauricette Michallet; Jacques-Olivier Bay; Jean-Yves Cahn; Eric De Coninck; Nathalie Dhedin; Marc Bernard; Bernard Rio; Agnès Buzyn; Anne Huynh; Karin Bilger; Pierre Bordigoni; Nathalie Contentin; Raphaël Porcher; Gérard Socié; Noel Milpied
Journal:  Br J Haematol       Date:  2010-12-07       Impact factor: 6.998

Review 6.  Allogeneic stem cell transplantation for myelofibrosis in 2012.

Authors:  Donal P McLornan; Adam J Mead; Graham Jackson; Claire N Harrison
Journal:  Br J Haematol       Date:  2012-03-29       Impact factor: 6.998

7.  Effects of spleen status on early outcomes after hematopoietic cell transplantation.

Authors:  G Akpek; M C Pasquini; B Logan; M-A Agovi; H M Lazarus; D I Marks; M Bornhaeüser; O Ringdén; R T Maziarz; V Gupta; U Popat; D Maharaj; B J Bolwell; J D Rizzo; K K Ballen; K R Cooke; P L McCarthy; V T Ho
Journal:  Bone Marrow Transplant       Date:  2012-12-10       Impact factor: 5.483

8.  Role of splenectomy in incidence and severity of acute graft-versus-host disease: a multicenter study of 157 patients.

Authors:  M Michallet; B Corront; J L Bosson; L Molina; B Peissel; D Maraninchi; J Reiffers; C Chabannon; M H Gaspard; A M Stoppa
Journal:  Bone Marrow Transplant       Date:  1991-07       Impact factor: 5.483

9.  Human CD5 promotes B-cell survival through stimulation of autocrine IL-10 production.

Authors:  Hélène Gary-Gouy; Julie Harriague; Georges Bismuth; Cornelia Platzer; Christian Schmitt; Ali H Dalloul
Journal:  Blood       Date:  2002-08-08       Impact factor: 22.113

Review 10.  Immune regulatory function of B cells.

Authors:  Claudia Mauri; Anneleen Bosma
Journal:  Annu Rev Immunol       Date:  2012-01-03       Impact factor: 28.527
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.